317 related articles for article (PubMed ID: 24625231)
1. Investigation of novel chemical inhibitors of human lysosomal acid lipase: virtual screening and molecular docking studies.
Azam SS; Abbasi SW; Tahir S
Comb Chem High Throughput Screen; 2014; 17(5):473-82. PubMed ID: 24625231
[TBL] [Abstract][Full Text] [Related]
2. Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.
Singh H; Singh JV; Gupta MK; Singh P; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Feb; 27(4):850-854. PubMed ID: 28117203
[TBL] [Abstract][Full Text] [Related]
3. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
4. Potential human cholesterol esterase inhibitor design: benefits from the molecular dynamics simulations and pharmacophore modeling studies.
John S; Thangapandian S; Lee KW
J Biomol Struct Dyn; 2012; 29(5):921-36. PubMed ID: 22292952
[TBL] [Abstract][Full Text] [Related]
5. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
6. High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors.
Veeramachaneni GK; Raj KK; Chalasani LM; Bondili JS; Talluri VR
Drug Des Devel Ther; 2015; 9():4397-412. PubMed ID: 26273199
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1.
Park H; Park SY; Ryu SE
J Mol Graph Model; 2013 Feb; 39():65-70. PubMed ID: 23220283
[TBL] [Abstract][Full Text] [Related]
8. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
9. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Savinainen JR; Käsnänen H; Xhaard H; Nevalainen T; Laitinen JT; Poso A; Leppänen J; Saario SM
ChemMedChem; 2009 Aug; 4(8):1253-9. PubMed ID: 19472270
[No Abstract] [Full Text] [Related]
10. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
John S; Thangapandian S; Sakkiah S; Lee KW
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
[TBL] [Abstract][Full Text] [Related]
11. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
12. Development of a selective activity-based probe for glycosylated LIPA.
Schwaid AG; Ruangsiriluk W; Reyes AR; Cabral S; Rajamohan F; Tu M; Ward J; Carpino PA
Bioorg Med Chem Lett; 2016 Apr; 26(8):1993-6. PubMed ID: 26965858
[TBL] [Abstract][Full Text] [Related]
13. Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors.
Zhou H; Wang C; Ye J; Chen H; Tao R
Gene; 2017 Dec; 637():63-71. PubMed ID: 28939339
[TBL] [Abstract][Full Text] [Related]
14. Use of an inhibitor to identify members of the hormone-sensitive lipase family.
Ben Ali Y; Chahinian H; Petry S; Muller G; Lebrun R; Verger R; Carrière F; Mandrich L; Rossi M; Manco G; Sarda L; Abousalham A
Biochemistry; 2006 Nov; 45(47):14183-91. PubMed ID: 17115713
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
Singh R; Pandey PN
Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a multi-domain structure for hormone-sensitive lipase.
Smith GM; Garton AJ; Aitken A; Yeaman SJ
FEBS Lett; 1996 Oct; 396(1):90-4. PubMed ID: 8906873
[TBL] [Abstract][Full Text] [Related]
17. New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.
Heng S; Tieu W; Hautmann S; Kuan K; Pedersen DS; Pietsch M; Gütschow M; Abell AD
Bioorg Med Chem; 2011 Dec; 19(24):7453-63. PubMed ID: 22075233
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
19. Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening.
Wu JS; Lin SY; Liao FY; Hsiao WC; Lee LC; Peng YH; Hsieh CL; Wu MH; Song JS; Yueh A; Chen CH; Yeh SH; Liu CY; Lin SY; Yeh TK; Hsu JT; Shih C; Ueng SH; Hung MS; Wu SY
J Med Chem; 2015 Oct; 58(19):7807-19. PubMed ID: 26348881
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Pancreatic Lipase Inhibitors Using
Panwar U; Singh SK
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):449-457. PubMed ID: 30484411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
